Progress towards the development of potent and selective inhibitors of the pro-survival protein Mcl-1 is reviewed.
No takes yet. Share an insight, caveat, or question.
Nhu et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: